Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women

Publish Year : 2016
Publisher : New England Journal of Medicine
Author Name : Nel A., van Niekerk N., Kapiga S., Bekker L.G., Gama C., Gill K., Kamali A., Kotze P., Louw C., Mabude Z., Miti N., Kusemererwa S., Tempelman H., Carstens H., Devlin B., Isaacs M., Malherbe M., Mans W., Nuttall J., Russell M., Ntshele S., Smit M., Solai L., Spence P., Steytler J., Windle K., Borremans M., Resseler S., Van Roey J., Parys W., Vangeneugden T., Van Baelen B., and Rosenberg Z.
Link : Click here

Description :

This article evaluates the safety and efficacy of a vaginal ring containing dapivirine for the prevention of HIV infection in nearly 2,000 women of reproductive age from South Africa and Uganda. The study was a randomized, double-blind, placebo-controlled trial and it found that the dapivirine ring was not associated with any safety concerns and was associated with a lower rate of HIV-1 infection than the placebo rate.

Recent Resource

The Global Fund Results Report 2017

This report highlights the need to address new HIV infections in adolescent girls and young women.

HIV/AIDS National Strategic Plans of Sub-Saharan African Countries: An Analysis for Gender Equality and Sex-Disaggregated HIV Targets

This analysis reveals a need to set disagreggated target to align an effective HIV response with...

Cash Transfers for HIV Prevention: What do Young Women Spend It On?

This study aimed to document spending patterns of young African women receiving cash transfers as...

View More